Unleashing nanotechnology to redefine tumor-associated macrophage dynamics and non-coding RNA crosstalk in breast cancer

Nanocarrier-based targeting tumor-associated macrophages can reprogram pro-tumor M2 macrophages into anti-tumor M1 macrophages, offering a promising approach for advanced breast cancer treatment. Image created in BioRender.com.